Login or sign up
For business
Average ratingGreat
4.1/ 5

Based on 8 reviews

538%
438%
325%
20%
10%
Ask AI

Ask Trustburn about Stimaire

Based on 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Tim Wilson
Reviews 1

I recently visited the website stimaire.com and I was impressed with the range of products they offer. The prices were reasonable and the product descriptions were detailed and helpful. I made a purchase and it arrived promptly. Overall, I had a great experience with Stimaire.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Stimaire

StimAire has invented a revolutionary neuromodulation platform that can be injected through a needle in a doctor’s office in under 15 minutes. Our first clinical target is obstructive sleep apnea which is a $30 billion market worldwide. Our device eliminates major surgery and a hospital stay, creating a patient-friendly solution for healthy sleep. The first…

StimAire: Revolutionizing Sleep Apnea Treatment with Neuromodulation

StimAire is a medical technology company that has developed a groundbreaking neuromodulation platform for the treatment of obstructive sleep apnea (OSA). With over 1 billion people worldwide suffering from sleep apnea, this condition is a major public health concern. StimAire's innovative device offers an effective and patient-friendly solution to this problem.

Traditionally, OSA has been treated with continuous positive airway pressure (CPAP) machines or surgery. However, these methods are often uncomfortable and invasive, leading many patients to avoid seeking treatment altogether. StimAire's device eliminates the need for major surgery and hospital stays by offering a minimally invasive alternative that can be administered in under 15 minutes in a doctor's office.

The neuromodulation platform works by delivering electrical impulses to the hypoglossal nerve, which controls the tongue muscles responsible for airway obstruction during sleep. By stimulating this nerve, StimAire's device helps keep the airway open during sleep without requiring any external equipment or devices.

StimAire's first clinical target is OSA, which represents a $30 billion market worldwide. The company has already completed successful clinical trials demonstrating the safety and efficacy of their device in treating OSA patients. In addition to its potential as an OSA treatment option, StimAire's neuromodulation platform also holds promise for other medical applications such as chronic pain management and epilepsy treatment.

StimAire was founded by Drs. David Pechman and Michael Friedman who have extensive experience in otolaryngology (ear nose throat) medicine and surgery respectively. Their combined expertise led them to develop this innovative solution for OSA patients who were not satisfied with traditional treatments.

In conclusion, StimAire is poised to revolutionize the way we treat obstructive sleep apnea with their neuromodulation platform. Their device offers a minimally invasive and patient-friendly alternative to traditional treatments, making it an attractive option for those suffering from this condition. With its potential for other medical applications, StimAire's technology has the potential to transform the healthcare industry as we know it.

Address
5181 north stonehouse place
Categories
Medical devices